Opendata, web and dolomites

DIABETESMART

The first Clinically Validated AI-powered Diabetes Assistant

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DIABETESMART project word cloud

Explore the words cloud of the DIABETESMART project. It provides you a very rough idea of what is the project "DIABETESMART" about.

class    fatal    cumulative    diabetesmart    66    easier    foresee    outperforms    danish    powered    415    patient    corporates    self    care    2015    prevalence    profits    12    phone    least    time    intelligent    25    sugar    company    estimate    cagr    potentially    69    employees    life    compliant    2016    clinical    forecast    642    country    wearable    hedia    daily    revenues    obtain    device    2040    children    iia    individuals    shown    mission    provides    platform    europes    normal    137    11    mdr    start    2021    pioneer    mobile    improvement    million    2017    81    validated    2026    app    artificial    globally    physician    integrate    people    200    diabetes    benefit    75    2045    recommendations    28b    mellitus    2022    medical    market    founded    thousand    clinically    lifestyle    ai    insights    chronic    live    glucose    team    diagnosed    complications    28    18m    19    stat    blood    26    context    10b       disease    bellow    health   

Project "DIABETESMART" data sheet

The following table provides information about the project.

Coordinator
HEDIA IVS 

Organization address
address: OLE MAALOES VEJ 3
city: KOBENHAVN
postcode: 2200
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HEDIA IVS DK (KOBENHAVN) coordinator 50˙000.00

Map

 Project objective

Diabetes mellitus, a common chronic disease that is associated with high blood glucose (also called blood sugar) can lead to potentially fatal health complications. Globally, 415 million people were diagnosed with diabetes in 2015, estimated to reach 642 million by 2040. In Europe disease prevalence is high, 66 million people were diagnosed in 2017, estimate to reach 81 million people by 2045, with 28,200 children (bellow 19 years old) diagnosed each year. Diabetes requires long-life care management from a physician care team and patient daily self-management. Improvement of diabetes self-care was shown when people with diabetes used mobile phone application. Yet, the challenge is to identify a clinical relevant App between the thousand diabetes management applications available in the market. Hedia, a Danish pioneer start-up company was founded with the mission to make life easier for people with diabetes. Based on the current challenges, we have developed a mobile platform for the daily diabetes management that outperforms the current stat-of-the-art: clinically validated Class IIA compliant to Europes’s new MDR; an artificial intelligent powered that provides tailored recommendations based on the individuals lifestyle and country context; integrate the user’s blood medical device and wearable of choice and other advanced features that enable people with diabetes live a normal life. DIABETESMART project targets the diabetes care market, which has an estimate value of €69.10B in 2016, forecast to reach €137.28B by 2022 with a 12.4% CAGR (2016-2022). We aim to offer DIABETESMART to corporates -who will obtain further revenues of €18M per year- and to people with diabetes who will benefit from real-time clinically meaningful insights based on AI by 2021. We foresee to reach revenues of €26.6 million with €75.1 million in cumulative profits and increase our team to at least 25 employees (from current 11) by 2026.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIABETESMART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIABETESMART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

AUTHEVOO (2019)

DNA-Authenticity & Traceability for Extra Virgin Olive Oil: Τrust the DNA, the label.

Read More